Heterogeneity of circulating tumor cells in neoadjuvant chemotherapy of breast cancer

The biological properties of circulating tumor cells (CTCs), and their dynamics during neoadjuvant chemotherapy are important, both for disease progression prediction and therapeutic target determination, with the aim of preventing disease progression. The aim of our study was to estimate of differe...

Full description

Bibliographic Details
Published in:Molecules Vol. 23, № 4. P. 727 (1-10)
Other Authors: Savelieva, Olga E., Tashireva, Liubov A., Tarabanovskaya, Natalia A., Simolina, Elena I., Denisov, Evgeny V., Slonimskaya, Elena M., Choynzonov, Evgeny L. 1952-, Perelmuter, Vladimir M., Kaigorodova, Evgeniya V.
Format: Article
Language:English
Subjects:
Online Access:http://vital.lib.tsu.ru/vital/access/manager/Repository/vtls:000787797
Перейти в каталог НБ ТГУ
LEADER 03015nab a2200433 c 4500
001 vtls000787797
003 RU-ToGU
005 20231212184533.0
007 cr |
008 201109|2018 sz s a eng d
024 7 |a 10.3390/molecules23040727  |2 doi 
035 |a to000787797 
039 9 |a 202011111259  |b 100  |c 202011091558  |d VLOAD  |y 202011091543  |z Александр Эльверович Гилязов 
040 |a RU-ToGU  |b rus  |c RU-ToGU 
245 1 0 |a Heterogeneity of circulating tumor cells in neoadjuvant chemotherapy of breast cancer  |c E. V. Kaigorodova, O. E. Savelieva, L. A. Tashireva [et al.] 
336 |a Текст 
337 |a электронный 
504 |a Библиогр.: 37 назв. 
520 3 |a The biological properties of circulating tumor cells (CTCs), and their dynamics during neoadjuvant chemotherapy are important, both for disease progression prediction and therapeutic target determination, with the aim of preventing disease progression. The aim of our study was to estimate of different CTC subsets in breast cancer during the NACT (neoadjuvant chemotherapy). The prospective study includes 27 patients with invasive breast cancer, T2-4N0-3M0, aged 32 to 60 years. Venous heparinized blood samples, taken before and after biopsy, after each courses of chemotherapy (on days 3-7), and before surgical intervention, served as the material for this study. Different subsets of circulating tumor cells were determined on the basis of the expression of EpCAM, CD45, CD44, CD24, and N-Cadherin using flow cytometry. As the result of this study, it has been observed that significant changes in the quantity of the different subsets of circulating tumor cells in patients' blood were observed after carrying out the 3rd course of NACT. NACT causes significant changes in the quantity of six CTC subsets, with various combinations of stemness and epithelial-mesenchymal transition (EMT) properties. 
653 |a рак молочной железы 
653 |a циркулирующие опухолевые клетки 
653 |a неоадъювантная химиотерапия 
653 |a гетерогенность 
655 4 |a статьи в журналах  |9 879358 
700 1 |a Savelieva, Olga E.  |9 478634 
700 1 |a Tashireva, Liubov A.  |9 208091 
700 1 |a Tarabanovskaya, Natalia A.  |9 102518 
700 1 |a Simolina, Elena I.  |9 473763 
700 1 |a Denisov, Evgeny V.  |9 96114 
700 1 |a Slonimskaya, Elena M.  |9 96118 
700 1 |a Choynzonov, Evgeny L.  |d 1952-  |9 106473 
700 1 |a Perelmuter, Vladimir M.  |9 96116 
700 1 |a Kaigorodova, Evgeniya V.  |9 102516 
773 0 |t Molecules  |d 2018  |g Vol. 23, № 4. P. 727 (1-10)  |x 1420-3049 
852 4 |a RU-ToGU 
856 4 |u http://vital.lib.tsu.ru/vital/access/manager/Repository/vtls:000787797 
856 |y Перейти в каталог НБ ТГУ  |u https://koha.lib.tsu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=473203 
908 |a статья 
999 |c 473203  |d 473203